Estrogenic effect of soy isoflavones on mammary gland morphogenesis and gene expression profile

Toxicological Sciences

Volumn 93, Issue 2, 2006, Pages 357-368

  Thomsen, Anni R ^a,b   Almstrup, Kristian ^b,d   Nielsen, John E ^b   Sørensen, Ilona K ^a   Petersen, Ole William ^c   Leffers, Henrik ^b   Breinholt, Vibeke M ^a,e  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d NOVO NORDISK A S   (Denmark)

^e Maxygen APS   (Denmark)

Author keywords

Development; Estradiol; Isoflavones; Mammary gland; Phytoestrogens

Indexed keywords

ESTRADIOL; ISOFLAVONE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL TISSUE; ARTICLE; BREAST DEVELOPMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; ESTROGEN ACTIVITY; ESTROGEN BLOOD LEVEL; FEMALE; GENE EXPRESSION PROFILING; GENE LOCATION; HORMONE ACTION; LACTATION; MALE; MAMMARY GLAND; MORPHOGENESIS; MOUSE; NONHUMAN; PERINATAL PERIOD; PUBERTY; TISSUE DISTRIBUTION; UPREGULATION;

ANIMALS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION PROFILING; IN SITU HYBRIDIZATION; ISOFLAVONES; MALE; MAMMARY GLANDS, ANIMAL; MICE; MORPHOGENESIS; SOYBEANS;

ANIMALIA; MURINAE;

EID: 33748745952     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfl029     Document Type: Article

References (42)

1. Adlercreutz, H., Markkanen, H., and Watanabe, S. (1993). Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342, 1209-1210.
2. Allred, C. D., Allred, K. F., Ju, Y. H., Goeppinger, T. S., Doerge, D. R., and Helferich, W. G. (2004). Soy processing influences growth of estrogen-dependent breast cancer tumors in mice. Carcinogenesis 15, 1649-1657.
3. Baik, I., Devito, W. J., Ballen, K., Becker, P. S., Okulicz, W., Liu, Q., Delpapa, E., Lagiou, P., Sturgeon, S., Trichopoulos, D., et al. (2005). Association of fetal hormone levels with stem cell potential: Evidence for early life roots of human cancer. Cancer Res. 1, 358-363.
4. Bernstein, L. (2002). Epidemiology of endocrine-related risk factors for breast cancer. J. Mammary Gland Biol. Neoplasia 7, 3-15.
5. Cabanes, A., Wang, M., Olivo, S., DeAssis, S., Gustafsson, J. A., Khan, G., and Hilakivi-Clarke, L. (2004). Pre-pubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis 5, 741-748.
6. Clarke, R. (2000). Introduction and overview: Sex steroids in the mammary gland. J. Mammary Gland Biol. Neoplasia 5, 245-250.
7. Day, J. K., Besch-Williford, C., McMann, T. R., Hufford, M. G., Lubahn, D. B., and MacDonald, R. S. (2001). Dietary genistein increased DMBA-induced mammary adenocarcinoma in wild-type, but not ER alpha KO, mice. Nutr. Cancer 39, 226-232.
8. Hatsumi, T., and Yamamuro, Y. (2006). Downregulation of estrogen receptor gene expression by exogenous 17β-estradiol in the mammary glands of lactating mice. Exp. Biol. Med. 231, 311-316.
9. Hewitt, S. C., Couse, J. F., and Korach, K. S. (2000). Estrogen receptor transcription and transactivation: Estrogen receptor knockout mice: What their phenotypes reveal about mechanisms of estrogen action. Breast Cancer Res. 2, 345-352.
10. Hilakivi-Clarke, L., Cho, E., and Clarke, R. (1998). Maternal genistein exposure mimics the effects of estrogen on mammary gland development in female mouse offspring. Oncol. Rep. 5, 609-616.
11. Hilakivi-Clarke, L., Cho, E., Onojafe, I., Raygada, M., and Clarke, R. (1999a). Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring. Oncol. Rep. 6, 1089-1095.
12. Hilakivi-Clarke, L., Onojafe, I., Raygada, M., Cho, E., Skaar, T., Russo, I., and Clarke, R. (1999b). Pre-pubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br. J. Cancer 80, 1682-1688.
13. Hoei-Hansen, C. E., Nielsen, J. E., Almstrup, K., Brask, S., Graem, N., Skakkebaek, N. E., Leffers, H., and Rajpert-De Meyts, E. (2004). Transcription factor AP-2γ is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors. Clin. Cancer Res. 10, 8521-8530.
14. Hovey, R. C., Trott, J. F., and Vonderhaar, B. K. (2002). Establishing a framework for the functional mammary gland: From endocrinology to morphology. J. Mammary Gland Biol. Neoplasia 7, 17-38.
15. Jefferson, W. N., Padilla-Banks, E., Clark, G., and Newbold, R. R. (2002). Assessing estrogenic activity of phytochemicals using transcriptional activation and immature mouse uterotrophic responses. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 25, 179-189.
16. Korach, K. S., Couse, J. F., Curtis, S. W., Washburn, T. F., Lindzey, J., Kimbro, K. S., Eddy, E. M., Migliaccio, S., Snedeker, S. M., Lubahn, D. B., et al. (1996). Estrogen receptor gene disruption: Molecular characterization and experimental and clinical phenotypes. Recent Prog. Horm. Res. 51, 159-188.
17. Kuiper, G. G., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B., and Gustafsson, J. A. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139, 4252-4263.
18. Lamorte, L., Rodrigues, S., Naujokas, M., and Park, M. (2002). Crk synergizes with epidermal growth factor for epithelial invasion and morphogenesis and is required for the met morphogenic program. J. Biol. Chem. 277, 37904-37911.
19. Livak, K. J., and Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) Method. Methods. 25, 402-408.
20. Luijten, M., Thomsen, A. R., van den Berg, J. A., Wester, P. W., Verhoef, A., Nagelkerke, N. J., Adlercreutz, H., van Kranen, H. J., Piersma, A. H., Sorensen, I. K., et al. (2004). Effects of soy-derived isoflavones and a high-fat diet on spontaneous mammary tumor development in Tg.NK (MMTV/c-neu) mice. Nutr. Cancer 50, 46-54.
21. Matsumura, A., Ghosh, A., Pope, G. S., and Darbre, P. D. (2005). Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. J. Steroid Biochem. Mol. Biol. 94, 431-443.
22. Matthews, J., and Gustafsson, J. A. (2003). Estrogen signaling: A subtle balance between ER alpha and ER beta. Mol. Interv. 3, 281-292.
23. Miyake, H., Gleave, M., Kamidono, S., and Hara, I. (2002). Overexpression of clusterin in transitional cell carcinoma of the bladder is related to disease progression and recurrence. Urology 59, 150-154.
24. Moggs, J. G., Ashby, J., Tinwellm, H., Limm, F. L., Moore, D. J., Kimber, I., and Orphanides, G. (2004). The need to decide if all estrogens are intrinsically similar. Environ. Health Perspect. 112, 1137-1142.
25. Mori, T., Nagasawa, H., and Bern, H. A. (1979). Long-term effects of perinatal exposure to hormones on normal and neoplastic mammary growth in rodents: A review. J. Environ. Pathol. Toxicol. 3, 191-205.
26. Murrill, W. B., Brown, N. M., Zhang, J. X., Manzotillo, P. A., Barnes, S., and Lamartiniere, C. A. (1996). Pre-pubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17, 1451-1457.
27. Newbold, R. R., Bullock, B. C., and McLachlan, J. A. (1990). Uterine adenocarcinoma in mice following developmental treatment with estrogens: A model for hormonal carcinogenesis. Cancer Res. 50, 7677-7681.
28. Nielsen, J. E., Hansen, M. A., Jørgensen, M., Tanaka, M., Almstrup, K., Skakkebaek, N. E., and Leffers, H. (2003). Germ cell differentiation-dependent and stage-specific expression of LANCL1 in rodent testis. Eur. J. Histol. 47, 215-222.
29. Nilsson, S., Makela, S., Treuter, E., Tujague, M., Thomsen, J., Andersson, G., Enmark, E., Pettersson, K., Warner, M., and Gustafsson, J. A. (2001). Mechanisms of estrogen action. Physiol. Rev. 81, 1535-1565.
30. Palmer, J., Wise, L. A., Robboy, S. J., Titus-Ernstoff, L., Noller, K. L., Herbst, A. L., Troisi, R., and Hoover, R. N. (2005). Hypospadias in sons of women exposed to diethylstilbestrol in utero. Epidemiology 16, 583-586.
31. Petersen, O. W., Gudjonsson, T., Villadsen, R., Bissell, M. J., and Ronnov-Jessen, L. (2003). Epithelial progenitor cell lines as models of normal breast morphogenesis and neoplasia. Cell Prolif. 36,(Suppl), 33-44.
32. Ray, G., Banerjee, S., Saxena, N. K., Campbell, D. R., Van Veldbuizen, P., and Banerjee, S. K. (2005). Stimulation of MCF-7 tumor progression in athymic nude mice by 17beta-estradiol induces WISP-2/CCN5 expression in xenografts: A novel signaling molecule in hormonal carcinogenesis. Oncol. Rep. 13, 445-448.
33. Redondo, M., Villar, E., Torres-Munoz, J., Tellez, T., Morell, M., and Petito, C. K. (2000). Overexpression of clusterin in human breast carcinoma. Am. J. Pathol. 157, 393-399.
34. Russo, I. H., and Russo, J. (1978). Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[a]anthracene. J. Natl. Cancer Inst. 61, 1439-1449.
35. Saunders, P. T. (1998). Oestrogen receptor beta (ER beta). Rev. Reprod. 3, 164-171.
36. Stingl, J., Raouf, A., Emerman, J. T.,. and Eaves, C. J. (2005). Epithelial progenitors in the normal human mammary gland. J. Mammary Gland Biol. Neoplasia 10, 49-59.
37. Thomsen, A. R., Mortensen, A., Breinholt, V. M., Lindecrona, R. H., Peñalvo, J. L., and Sørensen, I. K. (2005). Influence of Prevastein®, an isoflavone-rich soy product on mammary gland development and tumerigenesis. Nutr. Cancer 52, 176-188.
38. Trichopoulos, D. (1990). Hypothesis: Does breast cancer originate in utero? Lancet 21, 939-940.
39. Trougakos, I. P., and Gonos, E. S. (2002). Clusterin/apolipoprotein J in human aging and cancer. Int. J. Biochem. Cell Biol. 34, 1430-1448.
40. Turner, B. C., Zhang, J., Gumbs, A. A., Maher, M. G., Kaplan, L., Carter, D., Glazer, P. M., Hurst, H. C., Haffty, B. G., and Williams, T. (1998). Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer Res. 58, 5466-5472.
41. Waters, K. M., Safe, S., and Gaido, K. W. (2001). Differential gene expression in response to methoxychlor and estradiol through ERalpha, ERbeta, and AR in reproductive tissues of female mice. Toxicol. Sci. 63, 47-56.
42. Zhang, J., Brewer, S., Huang, J., and Williams, T. (2003). Overexpression of transcription factor AP-2alpha suppresses mammary gland growth and morphogenesis. Dev. Biol. 256, 127-145.